Trials / Unknown
UnknownNCT03238560
The Population Pharmacokinetics of Montelukast in Infants and Children
Population Pharmacokinetics of Montelukast in Infants and Children
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Shandong University · Academic / Other
- Sex
- All
- Age
- 1 Month – 12 Years
- Healthy volunteers
- Not accepted
Summary
The investigators' aim was to evaluate the population pharmacokinetics of montelukast in infants and children and define the appropriate dose in order to optimize Montelukast treatment in this vulnerable population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Montelukast Chewable Tablet | Montelukast treatment was used at a dosage of 5mg/day once daily |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2017-08-03
- Last updated
- 2017-08-03
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03238560. Inclusion in this directory is not an endorsement.